Andrew Gibson Selected Research

Andrew Gibson Research Topics

Disease

12	Hypersensitivity (Allergy) 02/2022 - 01/2013
5	Drug Hypersensitivity (Drug Allergy) 01/2021 - 01/2017
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 03/2015
3	Neoplasms (Cancer) 01/2021 - 12/2018
2	Chemical and Drug Induced Liver Injury 01/2021 - 11/2020
2	Cicatrix (Scar) 01/2021 - 01/2020
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021 - 11/2020
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2019 - 08/2018
2	Acute Coronary Syndrome 04/2018 - 02/2016
1	Drug Hypersensitivity Syndrome 01/2022
1	Eosinophilia 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2021
1	Vitiligo 11/2020
1	COVID-19 01/2020
1	Cytokine Release Syndrome 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Virus Diseases (Viral Diseases) 01/2019
1	Hepatitis C 01/2019
1	Myocardial Infarction 01/2019
1	Rheumatic Diseases (Rheumatism) 12/2018
1	Melanoma (Melanoma, Malignant) 12/2018
1	Schizophrenia (Dementia Praecox) 10/2017
1	Allergic Contact Dermatitis 10/2015
1	Lacrimal Duct Obstruction 10/2014
1	Iatrogenic Disease 02/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013
1	Acne Vulgaris 11/2012
1	Sacroiliitis 11/2012
1	Entropion 02/2010
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 01/2008
1	Inflammation (Inflammations) 01/2008
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 04/2007
1	Parkinsonian Disorders (Parkinsonism) 04/2007
1	Leg Ulcer 10/2005
1	Thrombosis (Thrombus) 10/2005
1	Vasculitis (Vasculitides) 10/2005
1	Infections 07/2003

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 03/2015
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	abacavir (Ziagen)FDA Link 01/2021 - 01/2021
2	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 12/2016
2	Tolvaptan FDA Link 01/2021 - 11/2020
2	HLA-B57 antigenIBA 01/2021 - 12/2016
2	Peptides (Polypeptides)IBA 01/2021 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2021
2	InterferonsIBA 01/2019 - 01/2013
2	TroponinIBA 01/2019 - 08/2018
2	HLA-B Antigens (HLA-B)IBA 01/2019 - 12/2016
2	Floxacillin (Flucloxacillin)IBA 12/2016 - 02/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	HLA-B*07 antigenIBA 01/2022
1	HLA-C Antigens (HLA-C)IBA 01/2022
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	GlycopeptidesIBA 01/2021
1	AcidsIBA 01/2021
1	KIR ReceptorsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	EnzymesIBA 01/2021
1	baricitinibIBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	telaprevirIBA 01/2019
1	Dapsone FDA Link 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	Troponin IIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	mesoglycanIBA 10/2017
1	ximelagatran (Exanta)IBA 12/2016
1	lumiracoxib (prexige)IBA 12/2016
1	Lapatinib (GW572016)FDA Link 12/2016
1	Oxypurinol (Oxipurinol)IBA 12/2016
1	AntigensIBA 10/2015
1	Tuberculin (PPD)IBA 10/2015
1	Hair DyesIBA 10/2015
1	4-phenylenediamine (p-phenylenediamine)FDA Link 10/2015
1	Bandrowski's baseIBA 10/2015
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2012
1	Tetracaine (Amethocaine)FDA LinkGeneric 02/2010
1	Prednisolone (Predate)FDA LinkGeneric 01/2008
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2008
1	Mitochondrial DNA (mtDNA)IBA 04/2007
1	Adenine Nucleotide Translocator 1IBA 04/2007
1	Erythropoietin FDA Link 10/2005
1	Chemokine CCL5IBA 07/2003

Therapy/Procedure

2	Cardiac Rehabilitation 04/2018 - 02/2016
1	Immunotherapy 01/2021
1	Therapeutics 12/2018
1	Massage (Zone Therapy) 10/2014
1	Sutures (Suture) 02/2010
1	Orthoptics (Orthoptic) 01/2008